Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.
about
Opioid antagonists for smoking cessationInterventions for preventing weight gain after smoking cessationSystematic review and meta-analysis of opioid antagonists for smoking cessationThe effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature reviewVarenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.Translational Research on Nicotine Dependence.Targeting nicotine addiction: the possibility of a therapeutic vaccine.The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatmentVarenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trialThe opioid receptors as targets for drug abuse medicationWeight gain in smokers after quitting cigarettes: meta-analysis.Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjectsA preliminary investigation of varenicline for heavy drinking smokers.Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersEffects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialConcordance between timeline follow-back and single-question assessment of self-reported smoking in a clinical trialThe effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats.Menthol cigarette use predicts treatment outcomes of weight-concerned smokers.Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.Endogenous opioid system: a promising target for future smoking cessation medications.Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.
P2860
Q24202118-BD6FC93C-AE6E-477F-BFC9-1A713CED63B4Q24203883-CA359EB4-5C70-4B1B-B47E-ADAFDF2B0CC2Q26853570-19DF0163-41D7-447F-B09D-811C4AF6BF12Q33892368-74CDF13F-3485-413F-9E27-E6ED3D3BEDD5Q34167551-43B88BE1-5D6C-4F15-9F57-DDFA8CDA01AFQ34513939-A5102CDE-2A26-4B7E-92AE-DB80C454B7B1Q34987300-F9E82656-78C4-4FD4-B592-FD5F91512183Q34988416-01DB7D42-48D5-4DBA-AA46-7102DBF345DAQ35195302-AF6D4692-E23D-4FD2-BEC2-73D40B8FB5F4Q35551196-38DCD947-F5CC-47DF-9325-61C176968FC1Q35978068-AB23C441-35D7-4D5E-8ABD-85C5105FA124Q36087096-C2CD8894-8EEF-44E0-9A18-604E0E143258Q36267094-3121506B-4845-403D-B057-7E479DD5941BQ36774139-89B57625-3DA8-47E5-AD7B-1DC08AE2F34DQ36800136-3C7262D3-CCB1-4FA5-B02A-B547A8639C66Q36821304-FEB1F7B0-F8FE-4CA3-90F6-5C3D7349D6A4Q36877440-E64CB131-BBC1-4532-B423-3DCFF8FCE3B9Q37179217-F32B2291-8CDB-4DA4-9292-03E349D5C0B4Q37280205-552AD5EC-5F4B-4D7C-A27F-708998748E2BQ37359319-5122145C-DB53-4CD6-8166-25930249DC9AQ37395560-8F7C873B-D33A-4A7C-B080-7AA7522C6037Q38594528-3C12B00C-5428-4A82-8D27-571C8C6FDF8DQ38747115-8C67AE6A-460E-4C02-AD1F-1EEEA6A8FF81Q47914487-C9008F43-B894-4279-A747-9189DF3B04B6Q50042559-4D5D4DD2-BC3B-453A-8C0F-DCD262C70681
P2860
Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@en
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@nl
type
label
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@en
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@nl
prefLabel
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@en
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@nl
P2093
P2860
P921
P1476
Low-dose naltrexone augmentati ...... ight gain: a randomized trial.
@en
P2093
Benjamin A Toll
Boris Meandzija
Marney White
Peter Jatlow
Robert Makuch
Stephanie S O'Malley
P2860
P304
P356
10.1016/J.DRUGALCDEP.2010.04.015
P577
2010-06-12T00:00:00Z